Results 11 to 20 of about 28,965 (255)

Single-cell transcriptomics reveals cell atlas and identifies cycling tumor cells responsible for recurrence in ameloblastoma

International Journal of Oral Science
Ameloblastoma is a benign tumor characterized by locally invasive phenotypes, leading to facial bone destruction and a high recurrence rate. However, the mechanisms governing tumor initiation and recurrence are poorly understood.
Gan Xiong, Nan Xie, Min Nie, Rongsong Ling, Bokai Yun, Jiaxiang Xie, Linlin Ren, Yaqi Huang, Wenjin Wang, Chen Yi, Ming Zhang, Xiuyun Xu, Caihua Zhang, Bin Zou, Leitao Zhang, Xiqiang Liu, Hongzhang Huang, Demeng Chen, Wei Cao, Cheng Wang   +19 more
doaj   +2 more sources

Bioengineering the ameloblastoma tumour to study its effect on bone nodule formation

Scientific Reports, 2021
Ameloblastoma is a benign, epithelial cancer of the jawbone, which causes bone resorption and disfigurement to patients affected. The interaction of ameloblastoma with its tumour stroma drives invasion and progression.
Deniz Bakkalci, Amrita Jay, Azadeh Rezaei, Christopher A. Howard, Håvard Jostein Haugen, Judith Pape, Shosei Kishida, Michiko Kishida, Gavin Jell, Timothy R. Arnett, Stefano Fedele, Umber Cheema   +11 more
doaj   +2 more sources

Epigenetic similarity between adenoid ameloblastoma and dentinogenic ghost cell tumour: DNA methylation analysis in odontogenic tumours. [PDF]

J Pathol Clin Res
Abstract Although adenoid ameloblastoma (AA) has recently been included in the WHO classification as a separate tumour type, its clinical, histological, immunohistochemical, and molecular similarities to dentinogenic ghost cell tumour (DGCT) raise questions about the current classification system. The aim of this study was to investigate the epigenetic
Oh KY.
europepmc   +2 more sources

Ameloblastoma: An Updated Narrative Review of an Enigmatic Tumor

Cureus, 2022
Ameloblastoma is one of the most common benign odontogenic tumors of the jaw that constitutes about 10% of all tumors that arise in the mandible and maxilla.
S. Ghai
semanticscholar   +1 more source

Clinicopathologic Profile, Management and Outcome of Sinonasal Ameloblastoma—A Systematic Review

Journal of Clinical Medicine, 2023
Sinonasal ameloblastoma (SNA) is considered to be a subtype of ameloblastoma. It differs from gnathic ameloblastoma in terms of clinicopathologic features, management and prognosis. Thus, the objective of the present review was to study the complications,
Vini Mehta, G. Sarode, Vishnu Teja Obulareddy, Tanvi Sharma, Shruti Kokane, M. Cicciù, G. Minervini   +6 more
semanticscholar   +1 more source

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

Medical Oncology, 2023
Background Ameloblastoma in 66% of the cases harbor a somatic mutation of the “mitogen-activated protein kinase” signaling pathway (BRAF V600E). In V600E mutations, BRAF is in the permanent “on” state and relays the growth-promoting signals independently
M. Ebeling, Mario Scheurer, A. Sakkas, S. Pietzka, A. Schramm, F. Wilde   +5 more
semanticscholar   +1 more source

The Role of BRAF Inhibitors in the Management of Ameloblastoma: A Literature Review

Cureus, 2023
Ameloblastoma is one of the most prevalent but enigmatic benign odontogenic tumors of the jaw, accounting for approximately 10% of all maxillary and mandibular tumors.
Arindam Malakar, V. R. Kumar, Priya Yadav, Vishal Bhardwaj, Chuimee Gogoi Barua, Gourika Bhardwaj   +5 more
semanticscholar   +1 more source

BRAF V600E Mutation in Ameloblastoma: A Systematic Review and Meta-Analysis

Cancers, 2022
Simple Summary Ameloblastoma is a benign odontogenic tumour, and the patient always presents at a later stage when the tumour is already in an aggressive state.
M. N. Mamat Yusof, E. Ch’ng, Nawal Radhiah Abdul Rahman   +2 more
semanticscholar   +1 more source

Differential diagnosis of ameloblastoma and odontogenic keratocyst by machine learning of panoramic radiographs

International Journal of Computer Assisted Radiology and Surgery, 2021
The differentiation of the ameloblastoma and odontogenic keratocyst directly affects the formulation of surgical plans, while the results of differential diagnosis by imaging alone are not satisfactory.
Zijia Liu, Jiannan Liu, Zijie Zhou, Qiaoyu Zhang, Hao Wu, Guangtao Zhai, Jing Han   +6 more
semanticscholar   +1 more source

Recurrent Ameloblastoma: Clinical Manifestation and Disease-Free Survival Rate

Journal of Oncology, 2022
Objectives Ameloblastoma is a slow-growing epithelial odontogenic neoplasm of the jaws with a high recurrence rate. The main treatment strategies for this lesion are radical or conservative surgical approaches. The aim of the present study was to analyze
Andrii Hresko, R. Palyvoda, Olha Burtyn, Y. Chepurnyi, A. Kopchak, M. Helder, T. Forouzanfar   +6 more
semanticscholar   +1 more source